ICUI vs. ALGN, MMSI, XRAY, HAE, QDEL, STAA, NEOG, CERS, OSUR, and UTMD
Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include Align Technology (ALGN), Merit Medical Systems (MMSI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), STAAR Surgical (STAA), Neogen (NEOG), Cerus (CERS), OraSure Technologies (OSUR), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry.
ICU Medical vs. Its Competitors
ICU Medical (NASDAQ:ICUI) and Align Technology (NASDAQ:ALGN) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.
96.1% of ICU Medical shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 1.5% of ICU Medical shares are held by company insiders. Comparatively, 0.7% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, Align Technology had 21 more articles in the media than ICU Medical. MarketBeat recorded 24 mentions for Align Technology and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.44 beat Align Technology's score of 1.05 indicating that ICU Medical is being referred to more favorably in the media.
ICU Medical currently has a consensus price target of $179.00, suggesting a potential upside of 42.48%. Align Technology has a consensus price target of $215.00, suggesting a potential upside of 59.61%. Given Align Technology's higher probable upside, analysts plainly believe Align Technology is more favorable than ICU Medical.
Align Technology has a net margin of 11.04% compared to ICU Medical's net margin of -1.56%. Align Technology's return on equity of 13.36% beat ICU Medical's return on equity.
ICU Medical has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500.
Align Technology has higher revenue and earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.
Summary
Align Technology beats ICU Medical on 12 of the 16 factors compared between the two stocks.
Get ICU Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ICU Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICUI) was last updated on 9/5/2025 by MarketBeat.com Staff